2-pyrrolino-dox has been researched along with Adenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arencibia, JM; Groot, K; Halmos, G; Koppán, M; Nagy, A; Plonowski, A; Schally, AV | 1 |
1 other study(ies) available for 2-pyrrolino-dox and Adenocarcinoma
Article | Year |
---|---|
Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Doxorubicin; Drug Delivery Systems; Gonadotropin-Releasing Hormone; Humans; Male; Mice; Mice, Nude; Models, Chemical; Polymerase Chain Reaction; Prostatic Neoplasms; Pyrroles; Receptors, LHRH; Transplantation, Heterologous; Tumor Cells, Cultured | 1999 |